Development of a preventive vaccine for filovirus infection in primates

US7635688B2 · kind B2 · utility

Assignee

• The United States of America, as represented by the Department of Health and Human Services · US

Inventors

• Gary J. Nabel · Cambridge, US
• Zhi-yong Yang · Potomac, US
• Nancy Sullivan · Kensington, US
• Anthony Sanchez · Lilburn, US

Key dates

• Filing date: Sep 24, 2002
• Grant date: Dec 22, 2009
• Expiry date: Sep 17, 2023

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2760/14222
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates generally to viral vaccines and, more particularly, to filovirus vaccines and methods of eliciting an immune response against a filovirus or disease caused by infection with filovirus.